Tornar a notícies
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
LuxQuanta capta 8 M€ per desplegar solucions de ciberseguretat quàntica.
Aquesta spin-off de l'ICFO es basa en la recerca liderada per l'investigador ICREA Valerio Pruneri, que també és membre fundador…
Premios Nacionales de Investigación 2025
Recentment, el Ministerio de Ciencia, Innovación y Universidades ha donat a conèixer els guardonats dels Premios Nacionales de Investigación. Una…
